US News

Drugmakers aim big price hikes at U.S. patients, congressional report finds

Published by

By Diane Bartz WASHINGTON (Reuters) -Drugmakers have targeted the U.S. market to earn outsized profits from old medicines, according to a report released on Friday by the House Oversight Committee that highlighted Eli Lilly and Co, Novo Nordisk and Sanofi, which dominate the market for insulin. The staff report also noted pricing and marketing tactics by Pfizer Inc that helped it earn billions of dollars from its now off-patent pain drug Lyrica. The report, put out following a nearly three-year probe, took issue with assertions by the pharmaceutical industry that high drug prices were needed t…

Read More

Facebook Comments

Check Also

New Zealand water ship unloads in Tonga as other aid trickles in

Published by Reuters By Praveen Menon, Kirsty Needham ...